High-risk hpv infection in sexually active and non active young women

• Authors: Zana Bumbuliene , Jonas Alisauskas , Agne Sepetiene
• Languages of publication: EN

Abstracts

EN

To determine the prevalence of high-risk HPV infection before first vaginal intercourse and after initiation of sexual activity in 14-22 years old girls, to find which HPV types occur most commonly. During the gynecologic exam cervical swabs were collected. Specimens were tested using Hybrid Capture 2 DNA test. In positive samples digene HPV genotyping test was performed. Subjects included 264 women, of whom 169 (64.0%) reported previous sexual activity and 95 (36.0%) had not yet had vaginal intercourse. There were 43 cases (16.3%) of high risk HPV, with 39 cases in those reporting sexual activity and 4 in virgins. Single strain HPV infection was detected in 62.8%, two strains in 23.2%, and three strains in 14.0% of subjects. HPV-16 was the most common type (20.9%), next more prevalent types were 18, 56, 31, 33 and 59. HPV-16 or HPV-18 were detected in 39.5% of the subjects. Not a single case was identified containing both types. The prevalence of high-risk HPV is common in sexually active young Lithuanian women. HPV were found in a small percentage of girls who had never had vaginal intercourse. The prevalence of types 16 and 18 among Lithuanian women was higher than in international data.

Keywords

EN

High-risk HPV prevalence; Virgins; Young women

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2011
• Volume: 6
• Issue: 4
• Pages: 456-462

Dates

published

1 - 8 - 2011

online

1 - 6 - 2011

Contributors

author

Zana Bumbuliene

• Faculty of Medicine, Clinic of Obstetrics and Gynecology, Vilnius University, LT-10207, Vilnius, Lithuania

author

Jonas Alisauskas

• Vilnius University Hospital Santariskiu Klinikos, LT-08662, Vilnius, Lithuania

author

Agne Sepetiene

• Vilnius University Hospital Santariskiu Klinikos, LT-08662, Vilnius, Lithuania

References

• [1] Cogliano V., Baan R., Straif K., et al., WHO International Agency for Research on Cancer: Carcinogenicity of human papillomaviruses, Lancet Oncol., 2005, 6(4), 204 http://dx.doi.org/10.1016/S1470-2045(05)70086-3[Crossref]
• [2] Bosch F.X., Lorincz A., Munoz N., et al., The causal relation between human papillomavirus and cervical cancer, J Clin Pathol., 2002, 55, 244–265 http://dx.doi.org/10.1136/jcp.55.4.244[Crossref]
• [3] Schiffman M., Clifford G., Buonaguro F.M., Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline, Infectious Agents and Cancer, 2009, 4, 8 http://dx.doi.org/10.1186/1750-9378-4-8[Crossref]
• [4] Marrazzo J., Koutsky L., Kiviat N., Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women, Am J Public Health, 2001, 91, 947–952 http://dx.doi.org/10.2105/AJPH.91.6.947[Crossref]
• [5] Moscicki A.B., Impact of HPV infection in adolescent populations, Journal of Adolescent Health, 2005, 37, S3–S9 http://dx.doi.org/10.1016/j.jadohealth.2005.09.011[Crossref]
• [6] Sonnex C., Strauss S., Gray J.J., Detection of human papillomavirus DNA on the fingers of patients with genital warts, Sex Transm Inf., 1999, 75, 317–319 http://dx.doi.org/10.1136/sti.75.5.317[Crossref]
• [7] Hernandez B.Y., Wilkens L.R., Zhu X., et al., Transmission of human papillomavirus in heterosexual couples, Emerging Infectious Diseases, 2008, 14(6), 888–894 http://dx.doi.org/10.3201/eid1406.070616.2[Crossref]
• [8] Smith J.S., Melendy A., Rana R.K., Pimenta J.M., Age-specific prevalence of infection with human papillomavirus in females: a global review, J Adolesc Health, 2008, 43(4), S5–25, S25 http://dx.doi.org/10.1016/j.jadohealth.2008.07.009[Crossref][WoS]
• [9] Shin H.R., Franceschi S., Vaccarella S., et al., Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea, The Journal of Infectious Diseases, 2004, 190, 468–476 http://dx.doi.org/10.1086/421279[Crossref]
• [10] Kliucinskas M., Nadisauskiene R.J., Minkauskiene M., Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women, Gynecol Obstet Invest., 2006, 62(3), 173–180 http://dx.doi.org/10.1159/000093572[Crossref]
• [11] Gudleviciene Z., Ramael M., Didziapetriene J., et al., Human papillomavirus and p53 polymorphism in Lithuanian cervical carcinoma patients, Oncology Gynecology, 2006, 102, 530–533 http://dx.doi.org/10.1016/j.ygyno.2006.01.019
• [12] Zhang W., Xue Y., Chen M., et al., Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized healthexamination women in Shanghai, China, Chinese Medical Journal, 2008, 121(16), 1578–1582
• [13] Tarkowski T.A., Koumans E.H., Sawyer M., et al., Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population, J Infect Dis., 2004, 189, 46–50 http://dx.doi.org/10.1086/380466[Crossref]
• [14] Stamataki P., Papazafiropoulou A., Elefsiniotis I., et al., Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic, BMC Infectious Diseases, 2010, 10, 27 http://dx.doi.org/10.1186/1471-2334-10-27[Crossref][WoS]
• [15] Winer R., Lee S., Hughes J., et al., Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students, Am J Epidemiol., 2003, 157, 218–226 http://dx.doi.org/10.1093/aje/kwf180[Crossref]
• [16] Moscicki A., Hills N., Shiboski S., et al., Risks for incident human papillomavirus infection and lowgrade squamous intraepithelial lesion development in young females, JAMA, 2001, 285, 2995–3002 http://dx.doi.org/10.1001/jama.285.23.2995[Crossref]
• [17] Dunne E.F., Unger E.R., Sternberg M., et al., Prevalence of HPV infection among females in the United States, JAMA, 2007, 297(8), 813–819 http://dx.doi.org/10.1001/jama.297.8.813[WoS][Crossref]
• [18] Steben M., Duarte-Franco E., Human papillomavirus infection: epidemiology and pathophysiology, Gynecologic Oncology, 2007, 107, S2–S5 http://dx.doi.org/10.1016/j.ygyno.2007.07.067[WoS][Crossref]
• [19] Marrazzo J., Koutsky L., Kiviat N., Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women, Am J Public Health, 2001, 91, 947–952 http://dx.doi.org/10.2105/AJPH.91.6.947[Crossref]
• [20] Mammas I.N., Sourvinos G., Spandidos D.A., Human papilloma virus (HPV) infection in children and adolescents, Eur J Pediatr., 2009, 168, 267–273 http://dx.doi.org/10.1007/s00431-008-0882-z[Crossref]
• [21] Jones V., Smith S.J., Omar H.A., Nonsexual transmission of anogenital warts in children: a retrospective analysis, ScientificWorld Journal, 2007, 7, 1896–1899 [Crossref]
• [22] Rylander E., Ruusuvaara L., Almstromer M.V., et al., The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse, Obstet Gynecol., 1994, 83, 735–737
• [23] Popendikyte V., Gulbinovic I., Paulauskiene V., Paulauskas D., High risk human papilloma virus detection and genotyping by multiplex PCR, Lithuanian Obstetrics and Gynecology, 2008, 4, 348–352
• [24] Brown D.R., Shew M.L., Qadadri B., et al., A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women, The Journal of Infectious Diseases, 2005, 191, 182–192 http://dx.doi.org/10.1086/426867[Crossref]
• [25] Schlecht N.F., Kulaga S., Robitaille J., et al., Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia, JAMA, 2001, 286, 3106–3114 http://dx.doi.org/10.1001/jama.286.24.3106[Crossref]
• [26] de Sanjosé S., Diaz M., Castellsagué X., et al., Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, Lancet Infect Dis., 2007, 7(7), 453–459 http://dx.doi.org/10.1016/S1473-3099(07)70158-5[Crossref][WoS]

Identifiers

DOI

10.2478/s11536-011-0042-0